A systematic review and meta-analysis on impact of suboptimal use of antidepressants, bisphosphonates, and statins on healthcare resource utilisation and healthcare cost.
<h4>Background</h4>Depression, osteoporosis, and cardiovascular disease impose a heavy economic burden on society. Understanding economic impacts of suboptimal use of medication due to nonadherence and non-persistence (non-MAP) for these conditions is important for clinical practice and...
Main Authors: | Kyu Hyung Park, Leonie Tickle, Henry Cutler |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0269836 |
Similar Items
-
Ethnic variation in asthma healthcare utilisation and exacerbation: systematic review and meta-analysis
by: AbdulQadr Akin-Imran, et al.
Published: (2023-05-01) -
Healthcare costs and resource utilisation in bronchiectasis, asthma and COPD
by: Raffaella Ronco, et al.
Published: (2023-07-01) -
Statin Pharmacogenomics: Opportunities to Improve Patient Outcomes and Healthcare Costs with Genetic Testing
by: William J. Canestaro, et al.
Published: (2012-10-01) -
Real world outcomes, healthcare utilisation and costs of Alzheimer's disease in England
by: Sophie Edwards, et al.
Published: (2024-03-01) -
Inpatient healthcare utilisation in patients with alcoholic liver disease: what are the costs and outcomes?
by: Williamson, KD, et al.
Published: (2016)